Click for best price
Antibacterial Drug Resistance Market Size, Share 2022
Antibacterial drug resistance is the process that bacteria use to tolerate and overcome the effects of antibiotic drugs. Resistance can arise through mutations or can be acquired from other bacteria through plasmids.
This report contains market size and forecasts of Antibacterial (Drug) Resistance in global, including the following market information:
Global Antibacterial (Drug) Resistance Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Antibacterial (Drug) Resistance Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Antibacterial (Drug) Resistance companies in 2021 (%)
The global Antibacterial (Drug) Resistance market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Telavancin (Vibativ) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Antibacterial (Drug) Resistance include Melinta Therapeutics, Allergan, Merck, Abbott Laboratories, Pfizer, GSK, PENDOPHARM, Absynth Biologics and Achaogen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Antibacterial (Drug) Resistance manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antibacterial (Drug) Resistance Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Antibacterial (Drug) Resistance Market Segment Percentages, by Type, 2021 (%)
Telavancin (Vibativ)
Ceftaroline Fosamil (Teflaro/ Zinforo)
Fidaxomicin (Dificid / Dificlir)
Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio)
Dalbavancin (Dalvance/ Xydalba)
Tedizolid Phosphate (Sivextro)
Oritavancin (Orbactiv/ Nuvocid)
Ceftolozane-Tazobactam (Zerbaxa)
Ceftazidime-Avibactam (Avycaz/ Zavicefta)
PHASE III DRUGS
Global Antibacterial (Drug) Resistance Market, by Indication, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Antibacterial (Drug) Resistance Market Segment Percentages, by Indication, 2021 (%)
Complicated Urinary Tract Infection (CUTI)
Complicated Intra-Abdominal Infections (CIAI)
Blood Stream Infections (BSI)
Clostridium Difficile Infections (CDI)
Acute Bacterial Skin And Skin Structure Infections (ABSSSI)
Hospital Acquired Bacterial Pneumonia/Ventilator (HABP/VABP)
Community Acquired Bacterial Pneumonia (CABP)
Global Antibacterial (Drug) Resistance Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Antibacterial (Drug) Resistance Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antibacterial (Drug) Resistance revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Antibacterial (Drug) Resistance revenues share in global market, 2021 (%)
Key companies Antibacterial (Drug) Resistance sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Antibacterial (Drug) Resistance sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Melinta Therapeutics
Allergan
Merck
Abbott Laboratories
Pfizer
GSK
PENDOPHARM
Absynth Biologics
Achaogen
Acino Holdings
Aventis Pharma
Austell Laboratories
Assembly Biosciences
Arpida
Demuris
Evolva Holding
ContraFect
Cerexa
InterMune
Isis Pharmaceuticals
Lyndra
Microbecide
Morphochem
Nabriva Therapeutics
NanoSafe Coatings
Novexel
Osel
VenatoRx Pharmaceuticals
AAIPharma Services
ANTABIO
| Report Attributes |
Report Details |
| Report Title |
Antibacterial (Drug) Resistance Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
129 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Antibacterial (Drug) Resistance Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Indication
1.3 Global Antibacterial (Drug) Resistance Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antibacterial (Drug) Resistance Overall Market Size
2.1 Global Antibacterial (Drug) Resistance Market Size: 2021 VS 2028
2.2 Global Antibacterial (Drug) Resistance Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Antibacterial (Drug) Resistance Sales: 2017-2028
3 Company Landscape
3.1 Top Antibacterial (Drug) Resistance Players in Global Market
3.2 Top Global Antibacterial (Drug) Resistance Companies Ranked by Revenue
3.3 Global Antibacterial (Drug) Resistance Revenue by Companies
3.4 Global Antibacterial (Drug) Resistance Sales by Companies
3.5 Global Antibacterial (Drug) Resistance Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Antibacterial (Drug) Resistance Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Antibacterial (Drug) Resistance Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antibacterial (Drug) Resistance Players in Global Market
3.8.1 List of Global Tier 1 Antibacterial (Drug) Resistance Companies
3.8.2 List of Global Tier 2 and Tier 3 Antibacterial (Drug) Resistance Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Antibacterial (Drug) Resistance Market Size Markets, 2021 & 2028
4.1.2 Telavancin (Vibativ)
4.1.3 Ceftaroline Fosamil (Teflaro/ Zinforo)
4.1.4 Fidaxomicin (Dificid / Dificlir)
4.1.5 Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio)
4.1.6 Dalbavancin (Dalvance/ Xydalba)
4.1.7 Tedizolid Phosphate (Sivextro)
4.1.8 Oritavancin (Orbactiv/ Nuvocid)
4.1.9 Ceftolozane-Tazobactam (Zerbaxa)
4.1.10 Ceftazidime-Avibactam (Avycaz/ Zavicefta)
4.1.11 PHASE III DRUGS
4.2 By Type - Global Antibacterial (Drug) Resistance Revenue & Forecasts
4.2.1 By Type - Global Antibacterial (Drug) Resistance Revenue, 2017-2022
4.2.2 By Type - Global Antibacterial (Drug) Resistance Revenue, 2023-2028
4.2.3 By Type - Global Antibacterial (Drug) Resistance Revenue Market Share, 2017-2028
4.3 By Type - Global Antibacterial (Drug) Resistance Sales & Forecasts
4.3.1 By Type - Global Antibacterial (Drug) Resistance Sales, 2017-2022
4.3.2 By Type - Global Antibacterial (Drug) Resistance Sales, 2023-2028
4.3.3 By Type - Global Antibacterial (Drug) Resistance Sales Market Share, 2017-2028
4.4 By Type - Global Antibacterial (Drug) Resistance Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Indication
5.1 Overview
5.1.1 By Indication - Global Antibacterial (Drug) Resistance Market Size, 2021 & 2028
5.1.2 Complicated Urinary Tract Infection (CUTI)
5.1.3 Complicated Intra-Abdominal Infections (CIAI)
5.1.4 Blood Stream Infections (BSI)
5.1.5 Clostridium Difficile Infections (CDI)
5.1.6 Acute Bacterial Skin And Skin Structure Infections (ABSSSI)
5.1.7 Hospital Acquired Bacterial Pneumonia/Ventilator (HABP/VABP)
5.1.8 Community Acquired Bacterial Pneumonia (CABP)
5.2 By Indication - Global Antibacterial (Drug) Resistance Revenue & Forecasts
5.2.1 By Indication - Global Antibacterial (Drug) Resistance Revenue, 2017-2022
5.2.2 By Indication - Global Antibacterial (Drug) Resistance Revenue, 2023-2028
5.2.3 By Indication - Global Antibacterial (Drug) Resistance Revenue Market Share, 2017-2028
5.3 By Indication - Global Antibacterial (Drug) Resistance Sales & Forecasts
5.3.1 By Indication - Global Antibacterial (Drug) Resistance Sales, 2017-2022
5.3.2 By Indication - Global Antibacterial (Drug) Resistance Sales, 2023-2028
5.3.3 By Indication - Global Antibacterial (Drug) Resistance Sales Market Share, 2017-2028
5.4 By Indication - Global Antibacterial (Drug) Resistance Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Antibacterial (Drug) Resistance Market Size, 2021 & 2028
6.2 By Region - Global Antibacterial (Drug) Resistance Revenue & Forecasts
6.2.1 By Region - Global Antibacterial (Drug) Resistance Revenue, 2017-2022
6.2.2 By Region - Global Antibacterial (Drug) Resistance Revenue, 2023-2028
6.2.3 By Region - Global Antibacterial (Drug) Resistance Revenue Market Share, 2017-2028
6.3 By Region - Global Antibacterial (Drug) Resistance Sales & Forecasts
6.3.1 By Region - Global Antibacterial (Drug) Resistance Sales, 2017-2022
6.3.2 By Region - Global Antibacterial (Drug) Resistance Sales, 2023-2028
6.3.3 By Region - Global Antibacterial (Drug) Resistance Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Antibacterial (Drug) Resistance Revenue, 2017-2028
6.4.2 By Country - North America Antibacterial (Drug) Resistance Sales, 2017-2028
6.4.3 US Antibacterial (Drug) Resistance Market Size, 2017-2028
6.4.4 Canada Antibacterial (Drug) Resistance Market Size, 2017-2028
6.4.5 Mexico Antibacterial (Drug) Resistance Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Antibacterial (Drug) Resistance Revenue, 2017-2028
6.5.2 By Country - Europe Antibacterial (Drug) Resistance Sales, 2017-2028
6.5.3 Germany Antibacterial (Drug) Resistance Market Size, 2017-2028
6.5.4 France Antibacterial (Drug) Resistance Market Size, 2017-2028
6.5.5 U.K. Antibacterial (Drug) Resistance Market Size, 2017-2028
6.5.6 Italy Antibacterial (Drug) Resistance Market Size, 2017-2028
6.5.7 Russia Antibacterial (Drug) Resistance Market Size, 2017-2028
6.5.8 Nordic Countries Antibacterial (Drug) Resistance Market Size, 2017-2028
6.5.9 Benelux Antibacterial (Drug) Resistance Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Antibacterial (Drug) Resistance Revenue, 2017-2028
6.6.2 By Region - Asia Antibacterial (Drug) Resistance Sales, 2017-2028
6.6.3 China Antibacterial (Drug) Resistance Market Size, 2017-2028
6.6.4 Japan Antibacterial (Drug) Resistance Market Size, 2017-2028
6.6.5 South Korea Antibacterial (Drug) Resistance Market Size, 2017-2028
6.6.6 Southeast Asia Antibacterial (Drug) Resistance Market Size, 2017-2028
6.6.7 India Antibacterial (Drug) Resistance Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Antibacterial (Drug) Resistance Revenue, 2017-2028
6.7.2 By Country - South America Antibacterial (Drug) Resistance Sales, 2017-2028
6.7.3 Brazil Antibacterial (Drug) Resistance Market Size, 2017-2028
6.7.4 Argentina Antibacterial (Drug) Resistance Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Antibacterial (Drug) Resistance Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Antibacterial (Drug) Resistance Sales, 2017-2028
6.8.3 Turkey Antibacterial (Drug) Resistance Market Size, 2017-2028
6.8.4 Israel Antibacterial (Drug) Resistance Market Size, 2017-2028
6.8.5 Saudi Arabia Antibacterial (Drug) Resistance Market Size, 2017-2028
6.8.6 UAE Antibacterial (Drug) Resistance Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Melinta Therapeutics
7.1.1 Melinta Therapeutics Corporate Summary
7.1.2 Melinta Therapeutics Business Overview
7.1.3 Melinta Therapeutics Antibacterial (Drug) Resistance Major Product Offerings
7.1.4 Melinta Therapeutics Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.1.5 Melinta Therapeutics Key News
7.2 Allergan
7.2.1 Allergan Corporate Summary
7.2.2 Allergan Business Overview
7.2.3 Allergan Antibacterial (Drug) Resistance Major Product Offerings
7.2.4 Allergan Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.2.5 Allergan Key News
7.3 Merck
7.3.1 Merck Corporate Summary
7.3.2 Merck Business Overview
7.3.3 Merck Antibacterial (Drug) Resistance Major Product Offerings
7.3.4 Merck Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.3.5 Merck Key News
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Corporate Summary
7.4.2 Abbott Laboratories Business Overview
7.4.3 Abbott Laboratories Antibacterial (Drug) Resistance Major Product Offerings
7.4.4 Abbott Laboratories Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.4.5 Abbott Laboratories Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Antibacterial (Drug) Resistance Major Product Offerings
7.5.4 Pfizer Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.5.5 Pfizer Key News
7.6 GSK
7.6.1 GSK Corporate Summary
7.6.2 GSK Business Overview
7.6.3 GSK Antibacterial (Drug) Resistance Major Product Offerings
7.6.4 GSK Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.6.5 GSK Key News
7.7 PENDOPHARM
7.7.1 PENDOPHARM Corporate Summary
7.7.2 PENDOPHARM Business Overview
7.7.3 PENDOPHARM Antibacterial (Drug) Resistance Major Product Offerings
7.7.4 PENDOPHARM Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.7.5 PENDOPHARM Key News
7.8 Absynth Biologics
7.8.1 Absynth Biologics Corporate Summary
7.8.2 Absynth Biologics Business Overview
7.8.3 Absynth Biologics Antibacterial (Drug) Resistance Major Product Offerings
7.8.4 Absynth Biologics Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.8.5 Absynth Biologics Key News
7.9 Achaogen
7.9.1 Achaogen Corporate Summary
7.9.2 Achaogen Business Overview
7.9.3 Achaogen Antibacterial (Drug) Resistance Major Product Offerings
7.9.4 Achaogen Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.9.5 Achaogen Key News
7.10 Acino Holdings
7.10.1 Acino Holdings Corporate Summary
7.10.2 Acino Holdings Business Overview
7.10.3 Acino Holdings Antibacterial (Drug) Resistance Major Product Offerings
7.10.4 Acino Holdings Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.10.5 Acino Holdings Key News
7.11 Aventis Pharma
7.11.1 Aventis Pharma Corporate Summary
7.11.2 Aventis Pharma Antibacterial (Drug) Resistance Business Overview
7.11.3 Aventis Pharma Antibacterial (Drug) Resistance Major Product Offerings
7.11.4 Aventis Pharma Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.11.5 Aventis Pharma Key News
7.12 Austell Laboratories
7.12.1 Austell Laboratories Corporate Summary
7.12.2 Austell Laboratories Antibacterial (Drug) Resistance Business Overview
7.12.3 Austell Laboratories Antibacterial (Drug) Resistance Major Product Offerings
7.12.4 Austell Laboratories Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.12.5 Austell Laboratories Key News
7.13 Assembly Biosciences
7.13.1 Assembly Biosciences Corporate Summary
7.13.2 Assembly Biosciences Antibacterial (Drug) Resistance Business Overview
7.13.3 Assembly Biosciences Antibacterial (Drug) Resistance Major Product Offerings
7.13.4 Assembly Biosciences Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.13.5 Assembly Biosciences Key News
7.14 Arpida
7.14.1 Arpida Corporate Summary
7.14.2 Arpida Business Overview
7.14.3 Arpida Antibacterial (Drug) Resistance Major Product Offerings
7.14.4 Arpida Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.14.5 Arpida Key News
7.15 Demuris
7.15.1 Demuris Corporate Summary
7.15.2 Demuris Business Overview
7.15.3 Demuris Antibacterial (Drug) Resistance Major Product Offerings
7.15.4 Demuris Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.15.5 Demuris Key News
7.16 Evolva Holding
7.16.1 Evolva Holding Corporate Summary
7.16.2 Evolva Holding Business Overview
7.16.3 Evolva Holding Antibacterial (Drug) Resistance Major Product Offerings
7.16.4 Evolva Holding Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.16.5 Evolva Holding Key News
7.17 ContraFect
7.17.1 ContraFect Corporate Summary
7.17.2 ContraFect Business Overview
7.17.3 ContraFect Antibacterial (Drug) Resistance Major Product Offerings
7.17.4 ContraFect Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.17.5 ContraFect Key News
7.18 Cerexa
7.18.1 Cerexa Corporate Summary
7.18.2 Cerexa Business Overview
7.18.3 Cerexa Antibacterial (Drug) Resistance Major Product Offerings
7.18.4 Cerexa Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.18.5 Cerexa Key News
7.19 InterMune
7.19.1 InterMune Corporate Summary
7.19.2 InterMune Business Overview
7.19.3 InterMune Antibacterial (Drug) Resistance Major Product Offerings
7.19.4 InterMune Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.19.5 InterMune Key News
7.20 Isis Pharmaceuticals
7.20.1 Isis Pharmaceuticals Corporate Summary
7.20.2 Isis Pharmaceuticals Business Overview
7.20.3 Isis Pharmaceuticals Antibacterial (Drug) Resistance Major Product Offerings
7.20.4 Isis Pharmaceuticals Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.20.5 Isis Pharmaceuticals Key News
7.21 Lyndra
7.21.1 Lyndra Corporate Summary
7.21.2 Lyndra Business Overview
7.21.3 Lyndra Antibacterial (Drug) Resistance Major Product Offerings
7.21.4 Lyndra Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.21.5 Lyndra Key News
7.22 Microbecide
7.22.1 Microbecide Corporate Summary
7.22.2 Microbecide Business Overview
7.22.3 Microbecide Antibacterial (Drug) Resistance Major Product Offerings
7.22.4 Microbecide Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.22.5 Microbecide Key News
7.23 Morphochem
7.23.1 Morphochem Corporate Summary
7.23.2 Morphochem Business Overview
7.23.3 Morphochem Antibacterial (Drug) Resistance Major Product Offerings
7.23.4 Morphochem Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.23.5 Morphochem Key News
7.24 Nabriva Therapeutics
7.24.1 Nabriva Therapeutics Corporate Summary
7.24.2 Nabriva Therapeutics Business Overview
7.24.3 Nabriva Therapeutics Antibacterial (Drug) Resistance Major Product Offerings
7.24.4 Nabriva Therapeutics Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.24.5 Nabriva Therapeutics Key News
7.25 NanoSafe Coatings
7.25.1 NanoSafe Coatings Corporate Summary
7.25.2 NanoSafe Coatings Business Overview
7.25.3 NanoSafe Coatings Antibacterial (Drug) Resistance Major Product Offerings
7.25.4 NanoSafe Coatings Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.25.5 NanoSafe Coatings Key News
7.26 Novexel
7.26.1 Novexel Corporate Summary
7.26.2 Novexel Business Overview
7.26.3 Novexel Antibacterial (Drug) Resistance Major Product Offerings
7.26.4 Novexel Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.26.5 Novexel Key News
7.27 Osel
7.27.1 Osel Corporate Summary
7.27.2 Osel Business Overview
7.27.3 Osel Antibacterial (Drug) Resistance Major Product Offerings
7.27.4 Osel Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.27.5 Osel Key News
7.28 VenatoRx Pharmaceuticals
7.28.1 VenatoRx Pharmaceuticals Corporate Summary
7.28.2 VenatoRx Pharmaceuticals Business Overview
7.28.3 VenatoRx Pharmaceuticals Antibacterial (Drug) Resistance Major Product Offerings
7.28.4 VenatoRx Pharmaceuticals Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.28.5 VenatoRx Pharmaceuticals Key News
7.29 AAIPharma Services
7.29.1 AAIPharma Services Corporate Summary
7.29.2 AAIPharma Services Business Overview
7.29.3 AAIPharma Services Antibacterial (Drug) Resistance Major Product Offerings
7.29.4 AAIPharma Services Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.29.5 AAIPharma Services Key News
7.30 ANTABIO
7.30.1 ANTABIO Corporate Summary
7.30.2 ANTABIO Business Overview
7.30.3 ANTABIO Antibacterial (Drug) Resistance Major Product Offerings
7.30.4 ANTABIO Antibacterial (Drug) Resistance Sales and Revenue in Global (2017-2022)
7.30.5 ANTABIO Key News
8 Global Antibacterial (Drug) Resistance Production Capacity, Analysis
8.1 Global Antibacterial (Drug) Resistance Production Capacity, 2017-2028
8.2 Antibacterial (Drug) Resistance Production Capacity of Key Manufacturers in Global Market
8.3 Global Antibacterial (Drug) Resistance Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Antibacterial (Drug) Resistance Supply Chain Analysis
10.1 Antibacterial (Drug) Resistance Industry Value Chain
10.2 Antibacterial (Drug) Resistance Upstream Market
10.3 Antibacterial (Drug) Resistance Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Antibacterial (Drug) Resistance Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Antibacterial (Drug) Resistance in Global Market
Table 2. Top Antibacterial (Drug) Resistance Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Antibacterial (Drug) Resistance Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Antibacterial (Drug) Resistance Revenue Share by Companies, 2017-2022
Table 5. Global Antibacterial (Drug) Resistance Sales by Companies, (K Units), 2017-2022
Table 6. Global Antibacterial (Drug) Resistance Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Antibacterial (Drug) Resistance Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Antibacterial (Drug) Resistance Product Type
Table 9. List of Global Tier 1 Antibacterial (Drug) Resistance Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antibacterial (Drug) Resistance Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Antibacterial (Drug) Resistance Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Antibacterial (Drug) Resistance Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Antibacterial (Drug) Resistance Sales (K Units), 2017-2022
Table 15. By Type - Global Antibacterial (Drug) Resistance Sales (K Units), 2023-2028
Table 16. By Indication ? Global Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2021 & 2028
Table 17. By Indication - Global Antibacterial (Drug) Resistance Revenue (US$, Mn), 2017-2022
Table 18. By Indication - Global Antibacterial (Drug) Resistance Revenue (US$, Mn), 2023-2028
Table 19. By Indication - Global Antibacterial (Drug) Resistance Sales (K Units), 2017-2022
Table 20. By Indication - Global Antibacterial (Drug) Resistance Sales (K Units), 2023-2028
Table 21. By Region ? Global Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Antibacterial (Drug) Resistance Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Antibacterial (Drug) Resistance Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Antibacterial (Drug) Resistance Sales (K Units), 2017-2022
Table 25. By Region - Global Antibacterial (Drug) Resistance Sales (K Units), 2023-2028
Table 26. By Country - North America Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Antibacterial (Drug) Resistance Sales, (K Units), 2017-2022
Table 29. By Country - North America Antibacterial (Drug) Resistance Sales, (K Units), 2023-2028
Table 30. By Country - Europe Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Antibacterial (Drug) Resistance Sales, (K Units), 2017-2022
Table 33. By Country - Europe Antibacterial (Drug) Resistance Sales, (K Units), 2023-2028
Table 34. By Region - Asia Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Antibacterial (Drug) Resistance Sales, (K Units), 2017-2022
Table 37. By Region - Asia Antibacterial (Drug) Resistance Sales, (K Units), 2023-2028
Table 38. By Country - South America Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Antibacterial (Drug) Resistance Sales, (K Units), 2017-2022
Table 41. By Country - South America Antibacterial (Drug) Resistance Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Antibacterial (Drug) Resistance Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Antibacterial (Drug) Resistance Sales, (K Units), 2023-2028
Table 46. Melinta Therapeutics Corporate Summary
Table 47. Melinta Therapeutics Antibacterial (Drug) Resistance Product Offerings
Table 48. Melinta Therapeutics Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Allergan Corporate Summary
Table 50. Allergan Antibacterial (Drug) Resistance Product Offerings
Table 51. Allergan Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Merck Corporate Summary
Table 53. Merck Antibacterial (Drug) Resistance Product Offerings
Table 54. Merck Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Abbott Laboratories Corporate Summary
Table 56. Abbott Laboratories Antibacterial (Drug) Resistance Product Offerings
Table 57. Abbott Laboratories Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Pfizer Corporate Summary
Table 59. Pfizer Antibacterial (Drug) Resistance Product Offerings
Table 60. Pfizer Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. GSK Corporate Summary
Table 62. GSK Antibacterial (Drug) Resistance Product Offerings
Table 63. GSK Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. PENDOPHARM Corporate Summary
Table 65. PENDOPHARM Antibacterial (Drug) Resistance Product Offerings
Table 66. PENDOPHARM Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Absynth Biologics Corporate Summary
Table 68. Absynth Biologics Antibacterial (Drug) Resistance Product Offerings
Table 69. Absynth Biologics Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Achaogen Corporate Summary
Table 71. Achaogen Antibacterial (Drug) Resistance Product Offerings
Table 72. Achaogen Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Acino Holdings Corporate Summary
Table 74. Acino Holdings Antibacterial (Drug) Resistance Product Offerings
Table 75. Acino Holdings Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Aventis Pharma Corporate Summary
Table 77. Aventis Pharma Antibacterial (Drug) Resistance Product Offerings
Table 78. Aventis Pharma Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Austell Laboratories Corporate Summary
Table 80. Austell Laboratories Antibacterial (Drug) Resistance Product Offerings
Table 81. Austell Laboratories Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. Assembly Biosciences Corporate Summary
Table 83. Assembly Biosciences Antibacterial (Drug) Resistance Product Offerings
Table 84. Assembly Biosciences Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 85. Arpida Corporate Summary
Table 86. Arpida Antibacterial (Drug) Resistance Product Offerings
Table 87. Arpida Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 88. Demuris Corporate Summary
Table 89. Demuris Antibacterial (Drug) Resistance Product Offerings
Table 90. Demuris Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 91. Evolva Holding Corporate Summary
Table 92. Evolva Holding Antibacterial (Drug) Resistance Product Offerings
Table 93. Evolva Holding Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 94. ContraFect Corporate Summary
Table 95. ContraFect Antibacterial (Drug) Resistance Product Offerings
Table 96. ContraFect Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 97. Cerexa Corporate Summary
Table 98. Cerexa Antibacterial (Drug) Resistance Product Offerings
Table 99. Cerexa Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 100. InterMune Corporate Summary
Table 101. InterMune Antibacterial (Drug) Resistance Product Offerings
Table 102. InterMune Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 103. Isis Pharmaceuticals Corporate Summary
Table 104. Isis Pharmaceuticals Antibacterial (Drug) Resistance Product Offerings
Table 105. Isis Pharmaceuticals Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 106. Lyndra Corporate Summary
Table 107. Lyndra Antibacterial (Drug) Resistance Product Offerings
Table 108. Lyndra Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 109. Microbecide Corporate Summary
Table 110. Microbecide Antibacterial (Drug) Resistance Product Offerings
Table 111. Microbecide Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 112. Morphochem Corporate Summary
Table 113. Morphochem Antibacterial (Drug) Resistance Product Offerings
Table 114. Morphochem Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 115. Nabriva Therapeutics Corporate Summary
Table 116. Nabriva Therapeutics Antibacterial (Drug) Resistance Product Offerings
Table 117. Nabriva Therapeutics Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 118. NanoSafe Coatings Corporate Summary
Table 119. NanoSafe Coatings Antibacterial (Drug) Resistance Product Offerings
Table 120. NanoSafe Coatings Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 121. Novexel Corporate Summary
Table 122. Novexel Antibacterial (Drug) Resistance Product Offerings
Table 123. Novexel Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 124. Osel Corporate Summary
Table 125. Osel Antibacterial (Drug) Resistance Product Offerings
Table 126. Osel Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 127. VenatoRx Pharmaceuticals Corporate Summary
Table 128. VenatoRx Pharmaceuticals Antibacterial (Drug) Resistance Product Offerings
Table 129. VenatoRx Pharmaceuticals Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 130. AAIPharma Services Corporate Summary
Table 131. AAIPharma Services Antibacterial (Drug) Resistance Product Offerings
Table 132. AAIPharma Services Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 133. ANTABIO Corporate Summary
Table 134. ANTABIO Antibacterial (Drug) Resistance Product Offerings
Table 135. ANTABIO Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 136. Antibacterial (Drug) Resistance Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 137. Global Antibacterial (Drug) Resistance Capacity Market Share of Key Manufacturers, 2020-2022
Table 138. Global Antibacterial (Drug) Resistance Production by Region, 2017-2022 (K Units)
Table 139. Global Antibacterial (Drug) Resistance Production by Region, 2023-2028 (K Units)
Table 140. Antibacterial (Drug) Resistance Market Opportunities & Trends in Global Market
Table 141. Antibacterial (Drug) Resistance Market Drivers in Global Market
Table 142. Antibacterial (Drug) Resistance Market Restraints in Global Market
Table 143. Antibacterial (Drug) Resistance Raw Materials
Table 144. Antibacterial (Drug) Resistance Raw Materials Suppliers in Global Market
Table 145. Typical Antibacterial (Drug) Resistance Downstream
Table 146. Antibacterial (Drug) Resistance Downstream Clients in Global Market
Table 147. Antibacterial (Drug) Resistance Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Antibacterial (Drug) Resistance Segment by Type
Figure 2. Antibacterial (Drug) Resistance Segment by Indication
Figure 3. Global Antibacterial (Drug) Resistance Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Antibacterial (Drug) Resistance Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Antibacterial (Drug) Resistance Revenue, 2017-2028 (US$, Mn)
Figure 7. Antibacterial (Drug) Resistance Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Antibacterial (Drug) Resistance Revenue in 2021
Figure 9. By Type - Global Antibacterial (Drug) Resistance Sales Market Share, 2017-2028
Figure 10. By Type - Global Antibacterial (Drug) Resistance Revenue Market Share, 2017-2028
Figure 11. By Type - Global Antibacterial (Drug) Resistance Price (USD/Unit), 2017-2028
Figure 12. By Indication - Global Antibacterial (Drug) Resistance Sales Market Share, 2017-2028
Figure 13. By Indication - Global Antibacterial (Drug) Resistance Revenue Market Share, 2017-2028
Figure 14. By Indication - Global Antibacterial (Drug) Resistance Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Antibacterial (Drug) Resistance Sales Market Share, 2017-2028
Figure 16. By Region - Global Antibacterial (Drug) Resistance Revenue Market Share, 2017-2028
Figure 17. By Country - North America Antibacterial (Drug) Resistance Revenue Market Share, 2017-2028
Figure 18. By Country - North America Antibacterial (Drug) Resistance Sales Market Share, 2017-2028
Figure 19. US Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Antibacterial (Drug) Resistance Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Antibacterial (Drug) Resistance Sales Market Share, 2017-2028
Figure 24. Germany Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2017-2028
Figure 25. France Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Antibacterial (Drug) Resistance Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Antibacterial (Drug) Resistance Sales Market Share, 2017-2028
Figure 33. China Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2017-2028
Figure 37. India Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Antibacterial (Drug) Resistance Revenue Market Share, 2017-2028
Figure 39. By Country - South America Antibacterial (Drug) Resistance Sales Market Share, 2017-2028
Figure 40. Brazil Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Antibacterial (Drug) Resistance Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Antibacterial (Drug) Resistance Sales Market Share, 2017-2028
Figure 44. Turkey Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2017-2028
Figure 48. Global Antibacterial (Drug) Resistance Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Antibacterial (Drug) Resistance by Region, 2021 VS 2028
Figure 50. Antibacterial (Drug) Resistance Industry Value Chain
Figure 51. Marketing Channels
